PorcineReproductive and Respiratory Syndrome Vaccine Market, By Product Type(Modified Live Virus Vaccine, Inactivated Vaccine, and Subunit Vaccines), ByRoute of Administration (Intramuscular and Intradermal), By Virus Genotype(Type I and Type II), By Region (North America, Latin America, Europe, AsiaPacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlooks,and Opportunity Analysis, 2019-2027
Porcine reproductive andrespiratory syndrome (PRRS) is a viral disease which causes variousreproductive problems such as late term abortions, infertility, weak and stillborn piglets in sows and respiratory problems like labored breathing, fever andpneumonia in pigs of all age group. Porcine reproductive and respiratorysyndrome virus (PRRSV) is contagious which can be transmitted by infectiousaerosols or direct contact.
Porcine reproductive andrespiratory syndrome vaccines prevent the pigs from acquiring this syndrome.The vaccine is developed on the basis of two genotypes of the virus; Type I(European) and Type II (North American) and can be administered throughintramuscular route or intradermal route.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3285
Global Porcine Reproductive andRespiratory Syndrome Vaccine Market Dynamics
An increasing demand for porkmeat is expected to propel the market growth over the forecast period.According to the U.S Department of Agriculture - Foreign Agricultural Service(USDA – FAS), 2017, among the total meat consumption nearly 40.4% of pork meatis consumed globally.
Moreover, significant economiclosses to swine producers caused by the porcine reproductive and respiratoryvirus is expected to propel the market growth. For instance, according to thestatistics presented in the North American PRRS Symposium held in November2019, an around 62% out of total economic loss was reported in the pork meatproduction market, which is US$ 581 million, has occurred in the growing periodof the pigs due to the porcine reproductive and respiratory virus.
Global Porcine Reproductive andRespiratory Syndrome Vaccine Market - Regional Insights
North America accounted for thelargest market share in 2018 owing to launch and approval of new vaccines forthe porcine reproductive and respiratory syndrome in the region. For instance,in June 2018, Elanco Animal Health, a division of Eli Lily and Company,introduced a modified live respiratory vaccine, Prevacent PRRS to reduce theporcine reproductive and respiratory syndrome (PRRS), respiratory form, in twoweeks or older piglets. Similarly, in 2018, MSD Animal Health launched a needlefree device, IDAL 3G, with two injector heads for intradermal vaccination.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/porcine-reproductive-and-respiratory-syndrome-vaccine-market-3285
1The device makes the vaccineadministration a safer and less stressful procedure for the pigs and moreefficient and convenient for farmers. The device is used to administer vaccineslike PORCILIS PRRS, for porcine reproductive and respiratory syndrome virus andPORCILIS PCV ID, for porcine circovirus type 2 simultaneously.
Global Porcine Reproductive andRespiratory Syndrome Vaccine Market - Competitive Landscape
Key players operating in theporcine reproductive and respiratory syndrome vaccine market include Boehringer-IngelheimGmbH, Zoetis, MSD Animal Health, Bioveta, Phibro Animal Health, Ceva , AscentCorporation, Agrovet, Winsun Bio, Konipharm, Merck & Co., Inc., Elanco (EliLily and Company), and Ringpu (Tianjin) Bio-Pharmacy Co., Ltd.
Moreover, key players in themarket are focused on developing new products in order to enhance their marketshare. For instance, in October 2019, Boehringer-Ingelheim launched ReprocycParvoFLEX, a subunit vaccine for the swine fetuses to protect them from thetransplacental infections caused by porcine parovirus.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3285
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
